Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.
Company profile
Ticker
TDOC
Exchange
Website
CEO
Jason Gorevic
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Teladoc, Inc.
SEC CIK
Corporate docs
Subsidiaries
AcuteCare Telemedicine, LLC • Advance Medical, Inc. • AM Healthcare Management Consulting Sdn. Bhd. • Best Doctors Holdings, Inc. • Best Doctors International Insurance S.a.r.l. • Best Doctors, Inc. • BetterHelp, Inc. • C3O Corporation • Consultant Connect Limited • Diabeto Inc. ...
TDOC stock data
Analyst ratings and price targets
Latest filings (excl ownership)
S-8
Registration of securities for employees
1 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Teladoc Health Reports Fourth Quarter and Full Year 2022 Results
22 Feb 23
8-K
Cost Associated with Exit or Disposal Activities
18 Jan 23
8-K
Results of Operations and Financial Condition
9 Jan 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
8-K
Teladoc Health Names Laizer Kornwasser as President, Enterprise Growth & Global Markets
28 Oct 22
8-K
Teladoc Health Reports Third-Quarter 2022 Results
26 Oct 22
UPLOAD
Letter from SEC
6 Oct 22
CORRESP
Correspondence with SEC
3 Oct 22
Transcripts
TDOC
Earnings call transcript
2022 Q4
22 Feb 23
TDOC
Earnings call transcript
2022 Q3
27 Oct 22
TDOC
Earnings call transcript
2022 Q2
27 Jul 22
TDOC
Earnings call transcript
2022 Q1
28 Apr 22
TDOC
Earnings call transcript
2021 Q4
23 Feb 22
TDOC
Earnings call transcript
2021 Q4
27 Oct 21
TDOC
Earnings call transcript
2021 Q2
28 Jul 21
TDOC
Earnings call transcript
2021 Q1
29 Apr 21
TDOC
Earnings call transcript
2020 Q4
25 Feb 21
TDOC
Earnings call transcript
2020 Q3
28 Oct 20
Latest ownership filings
4
Daniel Trencher
20 Mar 23
144
Notice of proposed sale of securities
17 Mar 23
4
Daniel Trencher
7 Mar 23
4
Richard J Napolitano
7 Mar 23
4
Laizer Kornwasser
7 Mar 23
4
JASON N GOREVIC
7 Mar 23
4
Stephany Verstraete
7 Mar 23
4
Adam C Vandervoort
7 Mar 23
4
Vidya Raman-Tangella
7 Mar 23
4
Mala Murthy
7 Mar 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 918.18 mm | 918.18 mm | 918.18 mm | 918.18 mm | 918.18 mm | 918.18 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.27 bn | 1.14 bn | (no burn) | (no burn) |
| Cash used (since last report) | n/a | n/a | 3.42 bn | 3.07 bn | n/a | n/a |
| Cash remaining | n/a | n/a | -2.50 bn | -2.15 bn | n/a | n/a |
| Runway (months of cash) | n/a | n/a | -2.0 | -1.9 | n/a | n/a |
Institutional ownership, Q4 2022
87.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 432 |
| Opened positions | 81 |
| Closed positions | 115 |
| Increased positions | 106 |
| Reduced positions | 153 |
| 13F shares | Current |
|---|---|
| Total value | 3.18 tn |
| Total shares | 141.44 mm |
| Total puts | 4.70 mm |
| Total calls | 8.28 mm |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| ARK Investment Management | 18.93 mm | $447.66 bn |
| Vanguard | 14.48 mm | $342.36 bn |
| BLK Blackrock | 9.88 mm | $233.77 bn |
| CMTDF Sumitomo Mitsui Trust | 8.13 mm | $192.16 bn |
| Nikko Asset Management Americas | 8.13 mm | $192.08 bn |
| General Catalyst Group Management Holdings GP | 6.72 mm | $1.34 bn |
| Baillie Gifford & Co | 4.75 mm | $112.27 bn |
| STT State Street | 4.66 mm | $110.12 bn |
| State Of Michigan Retirement System | 3.78 mm | $89.47 bn |
| Kinnevik AB (publ) | 3.68 mm | $87.12 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Mar 23 | Daniel Trencher | Common Stock | Sell | Dispose S | No | Yes | 25.13 | 1,000 | 25.13 k | 25,520 |
| 3 Mar 23 | Claus Torp Jensen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 37,202 | 0.00 | 37,202 |
| 3 Mar 23 | Andrew Turitz | Common Stock | Sell | Dispose S | No | No | 25.911 | 1,795 | 46.51 k | 22,806 |
| 3 Mar 23 | Andrew Turitz | RSU Common Stock | Grant | Acquire A | No | No | 0 | 37,202 | 0.00 | 37,202 |
| 3 Mar 23 | Michael Willem Waters | RSU Common Stock | Grant | Acquire A | No | No | 0 | 74,405 | 0.00 | 74,405 |
| 3 Mar 23 | Arnnon Geshuri | RSU Common Stock | Grant | Acquire A | No | No | 0 | 34,412 | 0.00 | 34,412 |
News
Credit Suisse Maintains Neutral on Teladoc Health, Lowers Price Target to $27
10 Mar 23
Analyst Expectations for Teladoc Health's Future
6 Mar 23
Wells Fargo Maintains Equal-Weight Rating for Teladoc Health: Here's What You Need To Know
6 Mar 23
Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $36
6 Mar 23
Wells Fargo Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $23
6 Mar 23
Press releases
Teladoc Health to Participate in Upcoming Investor Conference
3 Mar 23
Teladoc Health Reports Fourth Quarter and Full Year 2022 Results
22 Feb 23
Teladoc Health Releases Annual Corporate Social Responsibility Report
23 Jan 23
Moore Kuehn Encourages Investors of TELADOC HEALTH, INC. (NYSE: TDOC) to Contact Law Firm
6 Jan 23
Moore Kuehn Encourages Investors of TELADOC HEALTH, INC. (TDOC) to Contact Law Firm
6 Jan 23